1 |
Al Hamrashdi M, Brady G. Regulation of IRF3 activation in human antiviral signaling pathways[J]. Biochem Pharmacol, 2022, 200: 115026.
|
2 |
Chathuranga K, Weerawardhana A, Dodantenna N, et al. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing[J]. Exp Mol Med, 2021, 53(11): 1647-1668.
|
3 |
Liu S, Cai X, Wu J, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation[J]. Science, 2015, 347(6227): aaa2630.
|
4 |
Chattopadhyay S, Marques JT, Yamashita M, et al. Viral apoptosis is induced by IRF-3-mediated activation of Bax[J]. EMBO J, 2010, 29(10): 1762-1773.
|
5 |
Chattopadhyay S, Sen GC. IRF-3 and Bax: a deadly affair[J]. Cell Cycle 2010, 9(13): 2479-2480.
|
6 |
Hu LF, Li YX, Wang JZ, et al. Controlling CRISPR-Cas9 by guide RNA engineering[J]. Wiley Interdiscip Rev RNA, 2022: e1731.
|
7 |
Bellingham J, Gregory-Evans K, Gregory-Evans CY. Mapping of human interferon regulatory factor 3 (IRF3) to chromosome 19q13.3-13.4 by an intragenic polymorphic marker[J]. Ann Hum Genet, 1998, 62(Pt 3): 231-234.
|
8 |
Qin BY, Liu C, Lam SS, et al. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation[J]. Nat Struct Biol, 2003, 10(11): 913-921.
|
9 |
Takahasi K, Suzuki NN, Horiuchi M, et al. X-ray crystal structure of IRF-3 and its functional implications[J]. Nat Struct Biol, 2003, 10(11): 922-927.
|
10 |
Hiscott J. Triggering the innate antiviral response through IRF-3 activation[J]. J Biol Chem, 2007, 282(21): 15325-15329.
|
11 |
Suhara W, Yoneyama M, Kitabayashi I, et al. Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex[J]. J Biol Chem, 2002, 277(25): 22304-22313.
|
12 |
Weaver BK, Kumar KP, Reich NC. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1[J]. Mol Cell Biol, 1998, 18(3): 1359-1368.
|
13 |
Zierhut C, Yamaguchi N, Paredes M, et al. The cytoplasmic DNA sensor cGAS promotes mitotic cell death[J]. Cell, 2019, 178(2): 302-315 e23.
|
14 |
Chattopadhyay S, Sen GC. RIG-I-like receptor-induced IRF3 mediated pathway of apoptosis (RIPA): a new antiviral pathway[J]. Protein Cell, 2017, 8(3): 165-168.
|
15 |
Chattopadhyay S, Fensterl V, Zhang Y, et al. Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus[J]. J Virol, 2013, 87(1): 16-24.
|
16 |
Chattopadhyay S, Yamashita M, Zhang Y, et al. The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication[J]. J Virol, 2011, 85(8): 3708-3716.
|
17 |
White CL, Chattopadhyay S, Sen GC. Phosphatidylinositol 3-kinase signaling delays sendai virus-induced apoptosis by preventing XIAP degradation[J]. J Virol, 2011, 85(10): 5224-5227.
|
18 |
Chattopadhyay S, Kuzmanovic T, Zhang Y, et al. Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis[J]. Immunity, 2016, 44(5): 1151-1161.
|
19 |
Peters K, Chattopadhyay S, Sen GC. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence [J]. J Virol, 2008, 82(7): 3500-3508.
|
20 |
Cui YY, Zhao D, Sreevatsan S, et al. Mycobacterium bovis induces endoplasmic reticulum stress mediated-Apoptosis by activating IRF3 in a murine Macrophage cell line[J]. Front Cell Infect Microbiol, 2016, 6: 182.
|
21 |
Glanz A, Chawla K, Fabry S, et al. High throughput screening of FDA-approved drug library reveals the compounds that promote IRF3-mediated pro-apoptotic pathway inhibit virus replication[J]. Viruses, 2020, 12(4): 442.
|
22 |
Jiao S, Guan J, Chen M, et al. Targeting IRF3 as a YAP agonist therapy against gastric cancer[J]. J Exp Med, 2018, 215(2): 699-718.
|
23 |
Glanz A, Chakravarty S, Varghese M, et al. Transcriptional and non-transcriptional activation, posttranslational modifications, and antiviral functions of Interferon Regulatory Factor 3 and viral antagonism by the SARS-Coronavirus[J]. Viruses, 2021, 13(4): 575.
|
24 |
Petrasek J, Iracheta-Vellve A, Csak T, et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease[J]. Proc Natl Acad Sci USA, 2013, 110(41): 16544-16549.
|
25 |
Sanz-Garcia C, Poulsen KL, Bellos D, et al. The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice[J]. J Hepatol, 2019, 70(5): 974-984.
|
26 |
Zhang T, Zhang K, Ji K, et al. MicroRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions[J]. Cancer cell Int, 2020, 20(1): 549.
|
27 |
Wu J, Leng X, Pan Z, et al. Overexpression of IRF3 predicts poor prognosis in Clear Cell Renal Cell Carcinoma[J]. Int J Gen Med, 2021, 14: 5675-5692.
|
28 |
Bakhoum MF, Francis JH, Agustinus A, et al. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression[J]. Nat Commun, 2021, 12(1): 5402.
|
29 |
Mei Y, Cai D, Dai X. Modulating cancer stemness provides luminal a breast cancer cells with HER2 positive-like features[J]. J Cancer, 2020, 11(5): 1162-1169.
|
30 |
Li J, Ouyang J, Yuan J, et al. Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium Tuberculosis[J]. Infect Dis Pverty, 2022, 11(1): 31.
|